Efficacy and safety of dulaglutide in patients with absolute insulin deficiency
Objective. While dulaglutide has been approved inpatients with type 2 diabetes (T2DM) in combination with insulin, it has not been studied in insulin-deficient patients, not whether they have type 1 diabetes (T1DM) or T2DM. The aim of this study is to assess the efficacy and safety of dulaglutide 0....
Guardado en:
Autores principales: | Kutoh Eiji, Hayashi Jyunka, Kuto Alexandra N. |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Sciendo
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b286433da4974cd4b09087741399d287 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dulaglutide as an Effective Replacement for Prandial Insulin in Kidney Transplant Recipients with Type 2 Diabetes Mellitus: A Retrospective Review
por: Hwi Seung Kim, et al.
Publicado: (2021) -
Advances in the treatment of type 2 diabetes: impact of dulaglutide
por: Thompson AM, et al.
Publicado: (2016) -
Safety of Semaglutide
por: Mark M. Smits, et al.
Publicado: (2021) -
Corrigendum: Safety of Semaglutide
por: Mark M. Smits, et al.
Publicado: (2021) -
Temporal characterization of the insulin resistance during puberty in mice
por: Teixeira Pryscila D.S., et al.
Publicado: (2021)